...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Vascular and endovascular surgery >Transradial Access for Renal Artery Intervention is Feasible and Safe.
【24h】

Transradial Access for Renal Artery Intervention is Feasible and Safe.

机译：经radi动脉途径进行肾动脉介入治疗既可行又安全。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background: Transradial access for coronary intervention is associated with reduced access complications compared with transfemoral. Transradial access for renal artery intervention has been less well studied. Safety compared with transfemoral access is undetermined. Methods and Results: We evaluated the feasibility of transradial renal intervention (n = 11 patients) and compared safety parameters with a matched group of transfemoral controls (n = 44). All transradial interventions were successful with no complications. Femoral crossover was required in one due to insufficient guide length. Compared with transfemoral, there were fewer access complications in the transradial group (0 of 11 vs 3 of 44, P = .06) but no differences in fluoroscopy time or contrast volumes (25.3 +/- 14.4 vs 29.0 +/- 25.1 minutes, P = .47; 83.0 +/- 43.7 vs 82.6 +/- 35.2 cc, P = .97). At follow-up (median 6 months), radial patency was 100%. Creatinine and systolic blood pressure had decreased (mean 1.4 +/- 0.5 to 1.2 +/- 0.5, P = .06; 160 +/- 25 to 135 +/- 17, P = .009). Conclusions: Elective transradial renal intervention is feasible and safe. Radial-renal distance is a limitation with available guides.
机译：背景：与经股动脉相比，用于冠状动脉介入治疗的经is动脉入路可减少入路并发症。 renal动脉通路用于肾动脉介入治疗的研究较少。与经股入路相比，安全性尚未确定。方法和结果：我们评估了经radi肾介入治疗（n = 11例）的可行性，并将安全性参数与匹配的经股骨对照组（n = 44）进行了比较。所有经radi动脉干预均成功，无并发症。由于引导长度不足，因此需要进行股骨交叉。与经股骨相比，经radi骨组的入路并发症较少（11个中的0个，对比44个中的3个，P = .06），但透视时间或造影剂体积无差异（25.3 +/- 14.4 vs 29.0 +/- 25.1分钟， P = 0.47; 83.0 +/- 43.7 cc和82.6 +/- 35.2 cc，P = 0.97）。随访（中位6个月）时，radial骨通畅率为100％。肌酐和收缩压已降低（平均1.4 +/- 0.5至1.2 +/- 0.5，P = .06; 160 +/- 25至135 +/- 17，P = .009）。结论：选择性经trans动脉肾介入治疗可行，安全。 available肾距离是可用指南的限制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号